Kratom, a plant possessing opioid-like properties and sold over-the-counter, is facing increasing scrutiny from lawmakers on Capitol Hill. The growing regulatory attention stems from efforts by various states to implement bans on the natural product as well as its synthetic derivatives.
In response to these developments, federal lawmakers are calling for action. Specifically, Senator Chuck Grassley, a Republican from Iowa, has requested that the Trump administration take federal steps to address the compound.
In-depth summary · AI, neutral